Hsiu‐Chiung Yang

SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

Yumei Ye, Mandeep Bajaj, Hsiu‐Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2017 · 366 citations

Medicine, Pharmacology, Pharmacotherapy +17

Group-Specific Assays That Distinguish between the Four Major Types of Mammalian Phospholipase A2

Hsiu‐Chiung Yang, Marian Mosior, Chris A. Johnson et al. · Analytical Biochemistry · 1999 · 150 citations

Life Sciences, Biochemistry, Molecular Biology +10

Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes

Yochai Birnbaum, Mandeep Bajaj, Hsiu‐Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2018 · 124 citations

Medicine, Immunology, Pathology +14

Regional Distribution, Ontogeny, Purification, and Characterization of the Ca²⁺‐Independent Phospholipase A₂ from Rat Brain

Hsiu‐Chiung Yang, Marian Mosior, Binhui Ni et al. · Journal of Neurochemistry · 1999 · 122 citations

Life Sciences, Biochemistry, Molecular Biology +10

Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

Huan Chen, Da T. Tran, Hsiu‐Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2020 · 94 citations

Life Sciences, Molecular Biology, Pharmacology +16